Search

Ilia I. Ouspenski

Examiner (ID: 3638, Phone: (571)272-2920 , Office: P/1644 )

Most Active Art Unit
1644
Art Unit(s)
1644
Total Applications
1610
Issued Applications
1040
Pending Applications
153
Abandoned Applications
440

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 11421323 [patent_doc_number] => 20170029467 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-02-02 [patent_title] => 'METHOD OF PRODUCING BIVALIRUDIN' [patent_app_type] => utility [patent_app_number] => 15/168745 [patent_app_country] => US [patent_app_date] => 2016-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11198 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15168745 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/168745
METHOD OF PRODUCING BIVALIRUDIN May 30, 2016 Abandoned
Array ( [id] => 11113625 [patent_doc_number] => 20160310597 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-10-27 [patent_title] => 'Caspofungin Acetate Formulations' [patent_app_type] => utility [patent_app_number] => 15/165389 [patent_app_country] => US [patent_app_date] => 2016-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8440 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15165389 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/165389
Caspofungin Acetate Formulations May 25, 2016 Abandoned
Array ( [id] => 11289153 [patent_doc_number] => 20160339084 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-11-24 [patent_title] => 'Long-Acting Formulations of Insulin' [patent_app_type] => utility [patent_app_number] => 15/162563 [patent_app_country] => US [patent_app_date] => 2016-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 30334 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15162563 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/162563
Long-Acting Formulations of Insulin May 22, 2016 Abandoned
Array ( [id] => 11542627 [patent_doc_number] => 20170096451 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-04-06 [patent_title] => 'INHIBITION OF GLIADIN PEPTIDES' [patent_app_type] => utility [patent_app_number] => 15/160259 [patent_app_country] => US [patent_app_date] => 2016-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 16443 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15160259 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/160259
INHIBITION OF GLIADIN PEPTIDES May 19, 2016 Abandoned
Array ( [id] => 12702130 [patent_doc_number] => 20180125876 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-10 [patent_title] => Methods and Pharmaceutical Composition for Modulation Polarization and Activation of Macrophages [patent_app_type] => utility [patent_app_number] => 15/574868 [patent_app_country] => US [patent_app_date] => 2016-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15126 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15574868 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/574868
Methods and Pharmaceutical Composition for Modulation Polarization and Activation of Macrophages May 19, 2016 Abandoned
Array ( [id] => 17830097 [patent_doc_number] => 20220267401 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-25 [patent_title] => METHOD FOR PRODUCING AND PURIFYING HYBRID OR NON-HYBRID RECOMBINANT GLYCOPROTEIN HORMONES, HYBRID OR NON-HYBRID RECOMBINANT GLYCOPROTEIN HORMONES, EXPRESSION VECTORS AND USES OF THE RECOMBINANT GLYCOPROTEIN HORMONES [patent_app_type] => utility [patent_app_number] => 16/086284 [patent_app_country] => US [patent_app_date] => 2016-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5514 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16086284 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/086284
METHOD FOR PRODUCING AND PURIFYING HYBRID OR NON-HYBRID RECOMBINANT GLYCOPROTEIN HORMONES, HYBRID OR NON-HYBRID RECOMBINANT GLYCOPROTEIN HORMONES, EXPRESSION VECTORS AND USES OF THE RECOMBINANT GLYCOPROTEIN HORMONES May 9, 2016 Abandoned
Array ( [id] => 11656094 [patent_doc_number] => 09669076 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-06-06 [patent_title] => 'Albumin-free factor VIII formulations' [patent_app_type] => utility [patent_app_number] => 15/146835 [patent_app_country] => US [patent_app_date] => 2016-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7615 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15146835 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/146835
Albumin-free factor VIII formulations May 3, 2016 Issued
Array ( [id] => 12656929 [patent_doc_number] => 20180110809 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-04-26 [patent_title] => Bioassimilable protein-melanin complex, preparation and uses [patent_app_type] => utility [patent_app_number] => 15/569863 [patent_app_country] => US [patent_app_date] => 2016-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13270 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15569863 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/569863
Bioassimilable protein-melanin complex, preparation and uses Apr 28, 2016 Issued
Array ( [id] => 12584880 [patent_doc_number] => 20180086789 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-29 [patent_title] => PHARMACEUTICAL COMPOUND [patent_app_type] => utility [patent_app_number] => 15/569541 [patent_app_country] => US [patent_app_date] => 2016-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4208 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15569541 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/569541
PHARMACEUTICAL COMPOUND Apr 27, 2016 Abandoned
15/135625 Methods for Measuring Consumption of Amino Acid N-Carboxyanhydrides during Manufacture of Glatiramer Acetate Apr 21, 2016
Array ( [id] => 11046292 [patent_doc_number] => 20160243251 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-25 [patent_title] => 'ARTIFICIAL TRANSCRIPTION FACTORS COMPRISING A SLIDING DOMAIN AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 15/099371 [patent_app_country] => US [patent_app_date] => 2016-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 23678 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15099371 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/099371
Artificial transcription factors comprising a sliding domain and uses thereof Apr 13, 2016 Issued
Array ( [id] => 11099690 [patent_doc_number] => 20160296660 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-10-13 [patent_title] => 'COMPOSITIONS AND METHODS FOR PROMOTING HEMOSTASIS AND OTHER PHYSIOLOGICAL ACTIVITIES' [patent_app_type] => utility [patent_app_number] => 15/091435 [patent_app_country] => US [patent_app_date] => 2016-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 25193 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15091435 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/091435
Compositions and methods for promoting hemostasis and other physiological activities Apr 4, 2016 Issued
Array ( [id] => 12657091 [patent_doc_number] => 20180110863 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-04-26 [patent_title] => GLUCOSE-RESPONSIVE INSULIN CONJUGATES [patent_app_type] => utility [patent_app_number] => 15/564805 [patent_app_country] => US [patent_app_date] => 2016-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52680 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15564805 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/564805
GLUCOSE-RESPONSIVE INSULIN CONJUGATES Apr 3, 2016 Abandoned
Array ( [id] => 13311373 [patent_doc_number] => 20180207223 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-07-26 [patent_title] => PCSK9 INHIBITORY POLYPOLYPEPTIDES AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 15/558013 [patent_app_country] => US [patent_app_date] => 2016-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25795 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15558013 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/558013
PCSK9 INHIBITORY POLYPOLYPEPTIDES AND METHODS OF USE Mar 18, 2016 Abandoned
Array ( [id] => 12183307 [patent_doc_number] => 20180042243 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-02-15 [patent_title] => 'REAGENTS AND METHODS FOR INHIBITING OR DISRUPTING BIOFILM' [patent_app_type] => utility [patent_app_number] => 15/557812 [patent_app_country] => US [patent_app_date] => 2016-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 8632 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15557812 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/557812
Reagents and methods for inhibiting or disrupting biofilm Mar 10, 2016 Issued
Array ( [id] => 12204857 [patent_doc_number] => 20180050082 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-02-22 [patent_title] => 'SERPINS FOR THE TREATMENT OF NEUROINFLAMMATORY DISEASES' [patent_app_type] => utility [patent_app_number] => 15/556608 [patent_app_country] => US [patent_app_date] => 2016-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 17171 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15556608 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/556608
SERPINS FOR THE TREATMENT OF NEUROINFLAMMATORY DISEASES Mar 8, 2016 Abandoned
Array ( [id] => 11120633 [patent_doc_number] => 20160317607 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-11-03 [patent_title] => 'Purified Amphiphilic Peptide Compositions and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 15/065758 [patent_app_country] => US [patent_app_date] => 2016-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11496 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15065758 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/065758
Purified Amphiphilic Peptide Compositions and Uses Thereof Mar 8, 2016 Abandoned
Array ( [id] => 10978435 [patent_doc_number] => 20160175378 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-23 [patent_title] => 'NEW KETOGENIC DIET AND ITS USE IN TREATING THE CRITICALLY ILL' [patent_app_type] => utility [patent_app_number] => 15/056473 [patent_app_country] => US [patent_app_date] => 2016-02-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5714 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15056473 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/056473
NEW KETOGENIC DIET AND ITS USE IN TREATING THE CRITICALLY ILL Feb 28, 2016 Abandoned
Array ( [id] => 12831808 [patent_doc_number] => 20180169108 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-06-21 [patent_title] => Drug Combinations For the Treatment of HIV [patent_app_type] => utility [patent_app_number] => 15/552452 [patent_app_country] => US [patent_app_date] => 2016-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18328 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15552452 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/552452
Drug Combinations For the Treatment of HIV Feb 18, 2016 Abandoned
Array ( [id] => 13968307 [patent_doc_number] => 10213487 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-02-26 [patent_title] => Nasal powder formulation for treatment of hypoglycemia [patent_app_type] => utility [patent_app_number] => 15/545332 [patent_app_country] => US [patent_app_date] => 2016-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 11879 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15545332 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/545332
Nasal powder formulation for treatment of hypoglycemia Feb 15, 2016 Issued
Menu